272 related articles for article (PubMed ID: 16835486)
41. [Serum concentration and distribution in the liver, lung, heart and kidney of platinum after hepatic arterial injection in the form of cis-diammine dichloroplatinum microcapsule in rabbits].
Wang Y
Zhonghua Wai Ke Za Zhi; 1990 Nov; 28(11):686-8, 704. PubMed ID: 2086077
[TBL] [Abstract][Full Text] [Related]
42. [Anti-tumor activity of zinostatin stimalamer (YM 881) examined by human hepatoma cells in vitro and VX2 liver tumor in vivo].
Tanaka S; Fujihara A; Yamamoto M; Asano M; Ida H; Ohmi Y; Kitazaki T; Kikuchi Y; Yoshida S; Okamiya H
Gan To Kagaku Ryoho; 1994 Feb; 21(2):219-26. PubMed ID: 8311492
[TBL] [Abstract][Full Text] [Related]
43. [Quantitative assessment of lipiodol delivered intra-arterially into hepatoma: with evaluation of MR signal intensity].
Harada M; Yamashita Y; Yamamoto H; Yoshimatsu S; Sakamoto Y; Takahashi M
Nihon Igaku Hoshasen Gakkai Zasshi; 1993 Aug; 53(8):903-10. PubMed ID: 8396759
[TBL] [Abstract][Full Text] [Related]
44. Effects of hepatic artery chemoembolization using cisplatin-lipiodol suspension with gelatin sponge particles on swine liver.
Sahara S; Tanihata H; Sato M; Kawai N; Takasaka I; Minamiguchi H; Nakai M; Sonomura T
J Vasc Interv Radiol; 2009 Oct; 20(10):1359-64. PubMed ID: 19695901
[TBL] [Abstract][Full Text] [Related]
45. [Tissue tolerance to pelvic intraarterial chemoembolization].
Li J
Zhonghua Fu Chan Ke Za Zhi; 1993 Jan; 28(1):41-3, 61. PubMed ID: 8389277
[TBL] [Abstract][Full Text] [Related]
46. Transcatheter arterial embolization with cisplatin: apoptosis in VX2 tumour uterus transplants.
Harima Y; Harima K; Hasegawa T; Shikata N; Tanaka Y
Anticancer Res; 1996; 16(1):193-9. PubMed ID: 8615608
[TBL] [Abstract][Full Text] [Related]
47. [Effect of arterial administration of a high molecular weight anti-tumor agent styrene maleic acid neocarzinostatin for multiple small liver cancer].
Ikeda K; Saitoh S; Kumada H
Gan To Kagaku Ryoho; 1998 Feb; 25 Suppl 1():19-23. PubMed ID: 9512682
[TBL] [Abstract][Full Text] [Related]
48. [Intra-arterial chemotherapy with cisplatin-phosphatidylcholine-lipiodol suspension (CPLS) for invasive bladder cancer].
Yamashita S; Kanetake H; Saito Y; Nakashima M; Ogasawara M; Ichikawa M; Isomoto I; Matsunaga N
Gan To Kagaku Ryoho; 1992 Jul; 19(7):1087-9. PubMed ID: 1320848
[No Abstract] [Full Text] [Related]
49. Boron-lipiodol: a potential new drug for the treatment of liver tumors.
Lin WY; Chi CW; Ho YJ; Wu IC; Chung YT; Chen SD; Chou FI; Kai JJ; Lui WY; Chen TJ; Lin Y
Anticancer Res; 2002; 22(6C):3989-92. PubMed ID: 12553023
[TBL] [Abstract][Full Text] [Related]
50. [Effect of bismuth subnitrate on renal disorder after lipiodol-cisplatinum arterial infusion chemotherapy (first report)].
Ohsumi M; Iijima T; Koitabashi H; Nagamachi Y
Gan To Kagaku Ryoho; 1991 Jan; 18(1):131-4. PubMed ID: 1846281
[No Abstract] [Full Text] [Related]
51. Intraarterial infusion chemotherapy with lipiodol-CDDP suspension for hepatocellular carcinoma.
Yamamoto K; Shimizu T; Narabayashi I
Cardiovasc Intervent Radiol; 2000; 23(1):26-39. PubMed ID: 10656904
[TBL] [Abstract][Full Text] [Related]
52. [In vivo comparative study of the pharmacokinetics of chemotherapeutic agents infused via hepatic artery or portal vein against hepatic metastases. DRC Group].
Naomoto Y; Gochi A; Hizuta A; Iwagaki H; Matsuno T; Hamazaki K; Tanaka N; Orita K
Gan To Kagaku Ryoho; 1993 Aug; 20(11):1555-8. PubMed ID: 8373217
[TBL] [Abstract][Full Text] [Related]
53. Potential advantages of loco-regional intra-arterial chemotherapy.
Cagol PP; Pasqual E; Bacchetti S
In Vivo; 2006; 20(6A):777-9. PubMed ID: 17203767
[TBL] [Abstract][Full Text] [Related]
54. Distribution of platinum in the female genital tract and efficacy of radiotherapy combined with transcatheter arterial infusion of cisplatin for locally advanced stage IIIb carcinoma of the uterine cervix.
Nagai N; Kaneyasu Y; Komatsu M; Shiroyama Y; Oshita T; Watasaki S; Ito K
Oncol Rep; 2009 Mar; 21(3):585-91. PubMed ID: 19212615
[TBL] [Abstract][Full Text] [Related]
55. Systemic Lipoplatin infusion results in preferential tumor uptake in human studies.
Boulikas T; Stathopoulos GP; Volakakis N; Vougiouka M
Anticancer Res; 2005; 25(4):3031-9. PubMed ID: 16080562
[TBL] [Abstract][Full Text] [Related]
56. [Clinical study of the drug delivery in metastatic liver cancer using bromodeoxyuridine].
Taniguchi H; Shioaki Y; Daidoh T; Itoh A; Tsukuda N; Yamaguchi T; Sawai K; Takahashi T
Gan To Kagaku Ryoho; 1989 Aug; 16(8 Pt 2):3015-8. PubMed ID: 2551241
[TBL] [Abstract][Full Text] [Related]
57. [Comparison of pelvic transarterial chemoembolization with lipiodol ultra-fluid carboplatin and transarterial carboplatin through experiment in dogs].
Chen CL; Sun MH; Tan DC; Liang LZ
Ai Zheng; 2004 Nov; 23(11 Suppl):1405-8. PubMed ID: 15566645
[TBL] [Abstract][Full Text] [Related]
58. [Blood kinetics of free-platinum in CDDP hepato-arterial injection therapy].
Sakuma H; Kinami Y; Sekino H; Takeyama S; Nishida Y; Gabata T; Maeda M; Fushida S; Fujimura T; Yonemura Y
Gan To Kagaku Ryoho; 1991 Jul; 18(8):1357-62. PubMed ID: 2069406
[TBL] [Abstract][Full Text] [Related]
59. Basic and clinical research on the therapeutic effect of intervention in primary liver cancer by targeted intra-arterial verapamil infusion.
Pingsheng F; Tengyue Z; Qiang H; Qiang W; Xin S; Liting Q
Cell Biochem Biophys; 2012 Jan; 62(1):59-67. PubMed ID: 21830124
[TBL] [Abstract][Full Text] [Related]
60. [Clinical or experimental use of an anticancer drug-oil suspension and its characteristics].
Kaneko H; Yamakawa T; Yamanaka Y; Sekizawa Y; Togo S; Nishiyama K; Tsuchiya S
Gan To Kagaku Ryoho; 1986 Jul; 13(7):2363-9. PubMed ID: 3015042
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
